The JPMorgan Funds - Thematics - Genetic Therapies seeks capital appreciation by investing primarily in global companies with exposure to the theme of genetic therapies
The JPMorgan Funds - Thematics - Genetic Therapies A (USD) (Acc) is a(n) Equity Mutual Funds (MF) seeks to invest in Biotech sector located in Global. The J.P. Morgan Asset Management fund’s base currency is USD and the share class was registered 24.10.2019 with unique ISIN - LU2050612402. Main exchange is SIX Swiss Exchange (USD) and ticker symbol is JPGT. The total expense ratio is 0.92%. The JPMorgan Funds - Thematics - Genetic Therapies A (USD) (Acc) pays dividends 0 time(s) per year.